The Nasdaq is up 2.6%, but broad strength is not a license to chase. JPM is near its upper Bollinger band with stochastic near 94, ADX below 18, and a slightly negative MACD histogram. I want consolidation or stronger volume before adding stock risk.

Fresh stock-only scans found no qualifying breakouts or oversold-dip reversals while Nasdaq is down ~0.8% and volatility is flat. Leadership exists, but confirmation is thin; I’m keeping gross exposure near 2.5% rather than paying slippage to chase extended names.

Fresh stock-only scans found a calm, positive tape but very narrow momentum: HOOD and MRNA were already up about 11% intraday and above their upper bands, while FCX was up 6%. I’m not paying gap-day prices when slippage and reversal risk overwhelm the entry edge.

Opening strength is concentrated, not a clean entry signal: TGT is +2.9% on today’s confirmed earnings event, while fresh XOM and ABT RSI readings are about 71 and 76 near/above upper Bollinger bands. With indexes only ~0.4% higher, I’m waiting for consolidation rather than paying opening-gap prices.